These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6396063)

  • 1. [Effect of cyclophosphamide in experimental pyelonephritis in mice].
    Slavcheva E; Ivanova E; Georgiev D
    Eksp Med Morfol; 1984; 23(4):186-95. PubMed ID: 6396063
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunobacteriological aspects of pyelonephritis.
    Miller TE; Stewart E; North JD
    Contrib Nephrol; 1979; 16():11-5. PubMed ID: 380894
    [No Abstract]   [Full Text] [Related]  

  • 3. [Autovaccination in chronic pyelonephritis in the animal experiment--effect of cyclophosphamide on splenic and thymus lymphocytes].
    Straube E; Schütt W
    Z Urol Nephrol; 1987 Aug; 80(8):483-90. PubMed ID: 3318218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive treatment of experimental pyelonephritis with a combination of oxytetracycline and azathioprine.
    Hagemann I; Philipp H; Briedigkeit H; Dutz H
    Clin Nephrol; 1973; 1(6):372-6. PubMed ID: 4594998
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of autovaccination on the course of urinary tract infection in animal experiment.
    Straube E; Broschewitz U; Naumann G; Schill H
    J Hyg Epidemiol Microbiol Immunol; 1985; 29(4):435-46. PubMed ID: 3910724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of a newly synthesized immunosuppressor on the course of experimental pyelonephritis in mice].
    Slavcheva E; Ivanova E; Georgiev D
    Acta Microbiol Bulg; 1987; 21():82-8. PubMed ID: 3326402
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic pyelonephritis: modulation of host defenses by cyclosporin A.
    Findon G; Miller TE
    J Lab Clin Med; 1989 Aug; 114(2):157-64. PubMed ID: 2666534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of antibacterial effect of rifampicin and cephaloridine on a model of E. coli pyelonephritis in rats].
    Prát V; Konícková L; Hatala M
    Arzneimittelforschung; 1970 Apr; 20(4):554-7. PubMed ID: 4911591
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bacteriologic, histologic and functional studies of the kidney in 5 days' therapy of experimental E. coli pyelonephritis with gentamycin. Comparison with 9 days' therapy].
    Hagemann I; Briedigkeit H; Strangfeld D; Ditscherlein G; Schürer M; Pietsch R; Kruse I; Camu A; Blank W
    Z Urol Nephrol; 1985 Nov; 78(11):625-31. PubMed ID: 3913218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of active immunisation on ascending pyelonephritis in the rat.
    Radford NJ; Chick S; Ling R; Coles GA; Asscher AW
    J Pathol; 1974 Mar; 112(3):169-75. PubMed ID: 4601025
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of the chemotherapeutic effectiveness of mecillinam, ampicillin and their combination in coli bacillary pyelonephritis in rats].
    Zinchenko TA; Starkov MV; Rudzit EA; Lisitsa LI
    Antibiot Med Biotekhnol; 1986 Jan; 31(1):40-3. PubMed ID: 3511839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunobiologic factors in the pathogenesis of renal infection.
    Miller T; North D
    Kidney Int; 1979 Dec; 16(6):665-71. PubMed ID: 161989
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antibacterial effect of nalidixic acid in experimental acute Escherichia coli pyelonephritis].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Arztl Forsch; 1968 Feb; 22(2):69-72. PubMed ID: 4876157
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of chloramphenicol against different E. coli strains in vitro and in experimental pyelonephritis].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Arzneimittelforschung; 1968 Sep; 18(9):1123-7. PubMed ID: 4885372
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological enhancement in the pathogenesis of pyelonephritis.
    Miller TE; Burnham S; North JD
    Clin Exp Immunol; 1976 May; 24(2):336-45. PubMed ID: 776466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental studies on the etiology and pathogenesis of pyelonephritis].
    Mohr HJ
    Beitr Pathol Anat; 1969; 138(4):357-76. PubMed ID: 4239799
    [No Abstract]   [Full Text] [Related]  

  • 17. [Staphylococcal infection as a predisposing factor in experimental colipyelonephritis].
    Breunung M; Breunung MM; Peschel HG
    Padiatr Padol; 1971 Mar; 6(1):58-74. PubMed ID: 4949645
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute obstructive pyelonephritis (experimental research)].
    Rubtsov IuS
    Urol Nefrol (Mosk); 1986; (4):22-4. PubMed ID: 3532486
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dynamics of immunological changes in rabbits with experimental pyelonephritis].
    Shvedov LM; Skosogorenko MG; Ukhal' MI
    Urol Nefrol (Mosk); 1974; 0(5):10-3. PubMed ID: 4607553
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of cobra venom factor, an inhibitor of the complement system, on the sequence of morphological events in the rat kidney in experimental pyelonephritis.
    Sullivan MJ; Harvey RA; Shimamura T
    Yale J Biol Med; 1977; 50(3):267-73. PubMed ID: 329591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.